Related Experiment Videos
[Studies on midecamycin 4"-O-propionyltransferase gene structure]
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica
|December 1, 1996
Summary
The midecamycin propionyltransferase (mpt) gene was cloned and characterized. This gene enables the conversion of spiramycin into 4"-O-propionylspiramycin in Streptomyces species.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Context:
- Midecamycin propionyltransferase (mpt) gene is crucial for antibiotic modification.
- Understanding the genetic basis of antibiotic biosynthesis and modification is essential for developing new antimicrobial agents.
Purpose:
- To clone, characterize, and functionally express the midecamycin propionyltransferase (mpt) gene.
- To elucidate the genetic and molecular properties of the mpt gene and its product.
Summary:
- A restriction map of the 8.0 kb BamHI-BamHI DNA fragment containing the mpt gene was constructed.
- Southern blot analysis localized the mpt gene to a 3.0 kb EcoRI-EcoRI-PstI DNA fragment, which was subsequently cloned into the pWHM3 shuttle vector, yielding pWFPE.
- Sequence analysis revealed an open reading frame encoding a 388 amino acid protein with high similarity to the CarE product. The gene features a consensus ribosomal binding site and promoter elements, with an inverted repeat downstream serving as a transcriptional terminator.
Impact:
- The cloned mpt gene, when expressed in *S. ambofaciens* and *S. lividans*, confers the ability to convert spiramycin into 4"-O-propionylspiramycin.
- This research provides insights into the enzymatic modification of macrolide antibiotics and facilitates genetic engineering of antibiotic production in Streptomyces.